With cases of Ebola growing, the federal government is working to dramatically increase production of ZMapp, an experimental drug developed in San Diego, the The New York Times reported Wednesday.
Mapp Biopharmaceutical, a small biotech based in Sorrento Valley, said in August that all supplies of the drug had been exhausted.
The Times said that in addition to use of tobacco plants, two of the world’s biggest charities — the Bill & Melinda Gates Foundation and the Wellcome Trust — are seeking to produce ZMapp in animal cells, a more conventional approach.
In September, Mapp Biopharmaceutical was awarded a federal contract worth up to $42.3 million for development and clinical trials of ZMapp.
>> Subscribe to Times of San Diego’s free daily email newsletter! Click hereFollow Us: